Today: 29 April 2026
Tesco issues urgent “do not eat” recall for three pate lines after date-label error
4 January 2026
1 min read

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

LONDON, January 4, 2026, 13:02 ET

  • Tesco recalled three 170g own-brand pate products over an incorrect use-by date, the UK food watchdog said.
  • The Food Standards Agency warned of a possible “microbiological risk” and told shoppers to return affected packs for a refund.
  • The move comes as supermarkets face heightened scrutiny over labelling and recall compliance.

Britain’s Tesco has recalled three 170-gram own-brand pate products after they were labelled with an incorrect use-by date, prompting a warning over a possible microbiological risk, the UK’s Food Standards Agency said on Jan. 3. The recall covers Tesco Coarse Farmhouse Pate, Coarse Ardennes Pate and Smooth Chicken Liver Pate with a use-by date of 05 January 2026.

Use-by dates are safety deadlines for foods that spoil quickly, and the watchdog warns people should not eat food after that date even if it looks and smells normal. Mislabelled dates can leave shoppers relying on packaging that no longer reflects when the food is safe to eat.

Tesco told customers to return the affected date code to any Tesco store for a full refund and said no receipt was required. “No other Tesco products are affected by this recall,” the retailer said in a customer notice. Amazon Web Services, Inc.

The FSA said the products “may pose a microbiological risk,” a term used in food safety for harmful bacteria that can build up when chilled foods are kept too long or handled incorrectly.

The affected items are sold in 170g packs and include one chicken liver pate and two coarse pates, the notice showed. The date code in question is “05 JAN”.

Tesco said it would display point-of-sale notices in stores selling the products, a standard step designed to reach shoppers who may not see online recall updates. The FSA publishes such warnings as Product Recall Information Notices on its alerts page.

Competitive pressure is growing as peers also issue consumer notices. Waitrose said on Dec. 30 it recalled certain bottles of its No1 Deeside mineral and sparkling waters due to potential glass contamination and asked customers not to consume them and to return products for a refund.

But the key uncertainty is how many packs are already in households — and whether any have been eaten. The FSA notice did not mention reports of illness linked to the pates.

For Tesco, the practical test is execution: pulling affected stock quickly, getting clear in-store signage up, and handling refunds smoothly. The company directed customers to its contact channels for further information.

Stock Market Today

  • TSX Picks: Aecon Group, Savaria Among Undervalued Stocks with Upside Potential
    April 29, 2026, 9:24 AM EDT. Investors eye undervalued TSX stocks amid volatile fuel prices and steady interest rates. Aecon Group (TSX:ARE), a CA$3.36 billion construction firm, trades 24.8% below estimated fair value, boosted by rising Q1 sales and a strong project pipeline. Savaria Corporation (TSX:SIS), specializing in accessibility solutions with a CA$2.15 billion market cap, is down 32.2% against fair value. Both companies show promising earnings growth projections, potentially rewarding investors as market conditions stabilize. These stocks highlight opportunities found through cash flow-based valuation methods amid an uncertain economic backdrop.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
SailPoint stock slides 6% into 2026 — here’s what investors watch before Monday
Previous Story

SailPoint stock slides 6% into 2026 — here’s what investors watch before Monday

Exxon Mobil stock (XOM) in focus as U.S. presses oil majors on Venezuela ahead of Monday open
Next Story

Exxon Mobil stock (XOM) in focus as U.S. presses oil majors on Venezuela ahead of Monday open

Go toTop